MDS-482 Impact Of Magrolimab in Combination With Azacitidine on Red Blood Cells (RBCs) in Patients With Higher-Risk Myelodysplastic Syndromes (HR MDS) (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2152-2650(22)01421-5
Publication URI: https://api.elsevier.com/content/abstract/scopus_id/85138192854
Type: Journal Article/Review
Parent Publication: Clinical Lymphoma Myeloma and Leukemia